K-V Pharmaceutical Co

K-V Pharmaceutical Co. is a specialty pharmaceutical concern rooted in the prescription drug manufacturing segment (SIC 2834) that has historically focused on hormonally active treatments and critical care therapies, supplying hospitals, clinic systems, and specialty pharmacies that depend on reliable dosing and regulatory-compliant packaging; its core products include injectable contraceptives and hormone therapies, along with support programs for the clinicians and health systems that prescribe them. The company operates in an intensely regulated environment governed by the FDA and state boards, so shifts in approval timelines, safety findings, or reimbursement policies present material risks, and its small-cap structure makes squad-sized investments vulnerable to supply disruptions or increased scrutiny on manufacturing compliance. While the latest filing information is unknown, the profile reflects that K-V still must keep a close eye on inspection outcomes and patent-life exposure to retain customer confidence. Consider viewing live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025